ReShape Lifesciences Inc. (RSLS)

NASDAQ: RSLS · IEX Real-Time Price · USD

0.211

-0.009 (-3.95%)

At close: Jul 19, 2024, 4:00 PM

0.210

-0.001 (-0.61%)

Pre-market: Jul 22, 2024, 8:57 AM EDT

ReShape Lifesciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Net Income	-10.92	-11.39	-46.21	-63.15	-21.63	-23.68	Upgrade
Depreciation & Amortization	0.11	0.15	2.15	1.97	1.67	0.89	Upgrade
Share-Based Compensation	0.62	0.77	2.09	12.23	1.32	2.98	Upgrade
Other Operating Activities	-3.78	-6.49	20.07	33.57	10.09	-3.07	Upgrade
Operating Cash Flow	-13.97	-16.96	-21.9	-15.38	-8.55	-22.87	Upgrade
Capital Expenditures	-0	-0.01	-0.09	-0.35	-0.39	-0.19	Upgrade
Acquisitions	0	0	0	2.21	-2	0	Upgrade
Change in Investments	0	0	0	0	0	2.55	Upgrade
Investing Cash Flow	-0	-0.01	-0.09	1.86	-2.39	2.36	Upgrade
Share Issuance / Repurchase	7.37	17.57	3.13	46.03	0.68	23.38	Upgrade
Debt Issued / Paid	0	0	0	-12.73	10.4	-10	Upgrade
Other Financing Activities	-	-	-	-	-	0	Upgrade
Financing Cash Flow	7.37	17.57	3.13	33.3	11.08	13.38	Upgrade
Exchange Rate Effect	-0	0	0	0.03	-0.11	0	Upgrade
Net Cash Flow	-6.6	0.6	-18.86	19.81	0.02	-7.13	Upgrade
Free Cash Flow	-13.97	-16.97	-21.99	-15.73	-8.94	-23.06	Upgrade
Free Cash Flow Margin	-167.65%	-195.55%	-195.68%	-115.64%	-79.12%	-702.83%	Upgrade
Free Cash Flow Per Share	-0.60	-2.85	-51.83	-71.97	-114.48	-734.90	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).